Looking on the bright side, these new dates could spur a run up in price similar to what happened last fall, if we get listed on the Nasdaq well before Oct 31, which is likely. They are probably disspointed that there has been no real runup yet, and the reason for that is most likely that we are still on the OTC, and people are tapped out, and there is no real source of new buyers.
But, say, we get on the Nasdaq in a couple of weeks, then there will be quite a bit of time for new buyers to notice and and buy the stock.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links